» Articles » PMID: 34638583

Transcriptional Regulation of the Human IL5RA Gene Through Alternative Promoter Usage During Eosinophil Development

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Oct 13
PMID 34638583
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Regulation of the IL-5 receptor alpha () gene is complicated, with two known promoters (P1 and P2) driving transcription, and two known isoforms (transmembrane and soluble) dichotomously affecting the signaling potential of the protein products. Here, we sought to determine the patterns of P1 and P2 promoter usage and transcription factor occupancy during primary human eosinophil development from CD34 hematopoietic stem cell progenitors. We found that during eosinophilopoiesis, both promoters were active but subject to distinct temporal regulation, coincident with combinatorial interactions of transcription factors, including GATA-1, PU.1, and C/EBP family members. P1 displayed a relatively constant level of activity throughout eosinophil development, while P2 activity peaked early and waned thereafter. The soluble IL-5Rα mRNA peaked early and showed the greatest magnitude fold-induction, while the signaling-competent transmembrane isoform peaked moderately. Two human eosinophilic cell lines whose relative use of P1 and P2 were similar to eosinophils differentiated in culture were used to functionally test putative transcription factor binding sites. Transcription factor occupancy was then validated in primary cultures by ChIP. We conclude that IL-5-dependent generation of eosinophils from CD34 precursors involves complex and dynamic activity including both promoters, several interacting transcription factors, and both signaling and antagonistic protein products.

Citing Articles

Gene-Based Variant Analysis of Whole-Exome Sequencing in Relation to Eosinophil Count.

Hoglund J, Hadizadeh F, Ek W, Karlsson T, Johansson A Front Immunol. 2022; 13:862255.

PMID: 35935937 PMC: 9355086. DOI: 10.3389/fimmu.2022.862255.

References
1.
Gevaert P, Hellman C, Lundblad L, Lundahl J, Holtappels G, Van Cauwenberge P . Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients. Allergy. 2009; 64(5):725-32. DOI: 10.1111/j.1398-9995.2008.01885.x. View

2.
Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell M, Pirottin D . Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest. 2016; 126(9):3279-95. PMC: 5004964. DOI: 10.1172/JCI85664. View

3.
Lichtinger M, Ingram R, Hornef M, Bonifer C, Rehli M . Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J Biol Chem. 2007; 282(37):26874-26883. DOI: 10.1074/jbc.M703856200. View

4.
Gregory B, Kirchem A, Phipps S, Gevaert P, Pridgeon C, Rankin S . Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor.... J Immunol. 2003; 170(11):5359-66. DOI: 10.4049/jimmunol.170.11.5359. View

5.
Simon H, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K . Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 1997; 158(8):3902-8. View